These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16783394)

  • 1. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
    Muff MA; Masyuk TV; Stroope AJ; Huang BQ; Splinter PL; Lee SO; Larusso NF
    Lab Invest; 2006 Sep; 86(9):940-50. PubMed ID: 16783394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
    Masyuk TV; Huang BQ; Ward CJ; Masyuk AI; Yuan D; Splinter PL; Punyashthiti R; Ritman EL; Torres VE; Harris PC; LaRusso NF
    Gastroenterology; 2003 Nov; 125(5):1303-10. PubMed ID: 14598246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
    Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
    Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
    Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
    Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
    Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
    Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.
    Masyuk TV; Huang BQ; Masyuk AI; Ritman EL; Torres VE; Wang X; Harris PC; Larusso NF
    Am J Pathol; 2004 Nov; 165(5):1719-30. PubMed ID: 15509540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
    Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
    Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.
    Lee SO; Masyuk T; Splinter P; Banales JM; Masyuk A; Stroope A; Larusso N
    J Clin Invest; 2008 Nov; 118(11):3714-24. PubMed ID: 18949056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
    Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Masyuk AI; Gradilone SA; Gajdos GB; Chandok N; Bakeberg JL; Ward CJ; Ritman EL; Kiyokawa H; LaRusso NF
    Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells.
    Vroman B; LaRusso NF
    Lab Invest; 1996 Jan; 74(1):303-13. PubMed ID: 8569194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
    Nakanuma Y; Sato Y; Harada K
    Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy.
    Kelly KJ; Zhang J; Han L; Kamocka M; Miller C; Gattone VH; Dominguez JH
    PLoS One; 2015; 10(7):e0131677. PubMed ID: 26136112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat.
    Ren XS; Sato Y; Harada K; Sasaki M; Furubo S; Song JY; Nakanuma Y
    PLoS One; 2014; 9(1):e87660. PubMed ID: 24498161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
    PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD.
    Mason SB; Liang Y; Sinders RM; Miller CA; Eggleston-Gulyas T; Crisler-Roberts R; Harris PC; Gattone VH
    Anat Rec (Hoboken); 2010 Aug; 293(8):1279-88. PubMed ID: 20665806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
    Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
    JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.
    Gallagher AR; Esquivel EL; Briere TS; Tian X; Mitobe M; Menezes LF; Markowitz GS; Jain D; Onuchic LF; Somlo S
    Am J Pathol; 2008 Feb; 172(2):417-29. PubMed ID: 18202188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Hedgehog Signaling Attenuates Biliary Cystogenesis in the Polycystic Kidney (PCK) Rat.
    Sato Y; Yamamura M; Sasaki M; Harada K
    Am J Pathol; 2018 Oct; 188(10):2251-2263. PubMed ID: 30036521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKHD1 gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease.
    Yang J; Zhang S; Zhou Q; Guo H; Zhang K; Zheng R; Xiao C
    J Biochem Mol Biol; 2007 Jul; 40(4):467-74. PubMed ID: 17669261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats.
    Jiang L; Fang P; Septer S; Apte U; Pritchard MT
    Int J Toxicol; 2018; 37(4):308-326. PubMed ID: 29862868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.